Clinical Features and Outcomes of Acute Exacerbation in Chronic Obstructive Pulmonary Disease Patients with Pulmonary Heart Disease: A Multicenter Observational Study
- PMID: 34712043
- PMCID: PMC8547596
- DOI: 10.2147/COPD.S325925
Clinical Features and Outcomes of Acute Exacerbation in Chronic Obstructive Pulmonary Disease Patients with Pulmonary Heart Disease: A Multicenter Observational Study
Abstract
Purpose: To identify clinical features and outcomes associated with pulmonary heart disease among patients with chronic obstructive pulmonary disease exacerbation (COPD), which may help reduce economic burden accrued over hospital stay and shorten length of stay (LOS).
Patients and methods: Totally, 4386 patients with acute exacerbation of COPD (AECOPD) classified into pulmonary heart disease (PHD) group and non-pulmonary heart disease group, were included from the ACURE registry, a prospective multicenter patient registry study. Clinical features and outcomes were compared between groups.
Results: PHD patients had a more severe profile, including having higher scores of COPD assessment test and modified British Medical Research Council, worse lung function, more patients hospitalized more than once in the past year due to acute exacerbation of COPD, and more comorbidities. Furthermore, drug cost was higher and length of stay was longer in AECOPD patients with PHD.
Conclusion: AECOPD patients with PHD had a more severe profile and worse clinical outcomes, including higher drug cost and longer LOS. PHD is an independent risk factor of drug cost and LOS. Complicated with PHD in COPD/AECOPD patients with PHD means heavier disease burden and worse prognosis. It merits further study to focus on PHD management in COPD/AECOPD patients.
Keywords: chronic obstructive pulmonary disease; cost; exacerbation; length of stay; pulmonary heart disease.
© 2021 You et al.
Conflict of interest statement
The authors report no conflicts of interest in this work.
Figures
Similar articles
-
Outcomes associated with comorbid diabetes among patients with COPD exacerbation: findings from the ACURE registry.Respir Res. 2021 Jan 6;22(1):7. doi: 10.1186/s12931-020-01607-6. Respir Res. 2021. PMID: 33407433 Free PMC article.
-
Clinical and economic burden of comorbid coronary artery disease in patients with acute exacerbation of chronic obstructive pulmonary disease: sex differences in a nationwide cohort study.Respir Res. 2022 Feb 12;23(1):28. doi: 10.1186/s12931-022-01945-7. Respir Res. 2022. PMID: 35151338 Free PMC article.
-
Factors associated with a prolonged length of stay after acute exacerbation of chronic obstructive pulmonary disease (AECOPD).Int J Chron Obstruct Pulmon Dis. 2014 Jan 20;9:99-105. doi: 10.2147/COPD.S51467. eCollection 2014. Int J Chron Obstruct Pulmon Dis. 2014. PMID: 24477272 Free PMC article.
-
Characteristics, Management and In-Hospital Clinical Outcomes Among Inpatients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease in China: Results from the Phase I Data of ACURE Study.Int J Chron Obstruct Pulmon Dis. 2021 Feb 25;16:451-465. doi: 10.2147/COPD.S281957. eCollection 2021. Int J Chron Obstruct Pulmon Dis. 2021. PMID: 33658775 Free PMC article. Review.
-
Do Benefits Outweigh Risks for Corticosteroid Therapy in Acute Exacerbation of Chronic Obstructive Pulmonary Disease in People with Diabetes Mellitus?Int J Chron Obstruct Pulmon Dis. 2020 Mar 16;15:567-574. doi: 10.2147/COPD.S236305. eCollection 2020. Int J Chron Obstruct Pulmon Dis. 2020. PMID: 32214806 Free PMC article. Review.
Cited by
-
Risk Factors for Length of Hospital Stay in Acute Exacerbation Chronic Obstructive Pulmonary Disease: A Multicenter Cross-Sectional Study.Int J Gen Med. 2022 Mar 29;15:3447-3458. doi: 10.2147/IJGM.S354748. eCollection 2022. Int J Gen Med. 2022. PMID: 35378912 Free PMC article.
-
Exploring the mechanism of Lianhuaqingwen (LHQW) in treating chronic bronchitis based on network pharmacology and experimental validation.Respir Res. 2024 Aug 2;25(1):294. doi: 10.1186/s12931-024-02927-7. Respir Res. 2024. PMID: 39095732 Free PMC article.
-
Resting heart rate and risk of left and right heart failure in 0.5 million Chinese adults.Open Heart. 2022 May;9(1):e001963. doi: 10.1136/openhrt-2022-001963. Open Heart. 2022. PMID: 35649571 Free PMC article.
-
Effect of inhalation drug therapy on inflammatory factors and quality of life on stable chronic obstructive pulmonary disease.Pak J Med Sci. 2024 Aug;40(7):1403-1409. doi: 10.12669/pjms.40.7.7106. Pak J Med Sci. 2024. PMID: 39092055 Free PMC article.
References
-
- Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease 2021 report. Available from: https://goldcopd.org/2021-gold-reports/. Accessed October 8, 2021.
-
- Global and regional estimates of COPD prevalence: systematic review and meta-analysis - PubMed [Internet]; [cited June 16, 2021]. Available from: https://pubmed.ncbi.nlm.nih.gov/26755942/. Accessed October 8, 2021.
-
- World Health Organization. Projections of mortality and causes of death, 2016 and 2060. Available from: http://www.who.int/healthinfo/global_burden_disease/projections/en/. Accessed October, 2020.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous